secwatch / observer
8-K filed June 7, 2023, 7:59 PM ET ticker ARTW CIK 0000007623
other material confidence high sentiment positive materiality 0.60

ARTS WAY MANUFACTURING CO INC (ARTW): restructuring charge — Art's-Way Manufacturing to close Tools segment (American Carbide Tool) in Q3 FY2023

ARTS WAY MANUFACTURING CO INC

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

ARTS WAY MANUFACTURING CO INC announced a restructuring with charges of liquidation costs of approximately $200,000 affecting Tools segment (American Carbide Tool) (15 employees).

Type
restructuring
Charge
liquidation costs of approximately $200,000
Affected area
Tools segment (American Carbide Tool)
Headcount
15 employees
Exact text from the filing
The closure of American Carbide Tool ("ACT") is not expected to have a significant financial impact during the third quarter of fiscal year 2023, when the Company anticipates the operations of American Carbide Tool will cease. The Company expects to generate cash from the liquidation of receivables, inventory and other assets of $950,000 after operations cease, which will be used to fund liquidation costs of approximately $200,000. Additionally, the Company will market ACT’s land, building and equipment for sale. The real estate has been appraised at greater than net book value. Proceeds from the sale of the property are not included in the above-noted cash and financial impact estimates. The Company expects to incur substantially all of these costs, and to complete its closure plan, by the end of the fiscal year ending November 30, 2023. Closure of the Tools business is expected to impact 15 employees.
View on SEC.gov

Browse all restructurings & charges →

ARTS WAY MANUFACTURING CO INC filing history →

Source: SEC EDGAR
accession 0001437749-23-016854
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.